These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30536702)

  • 21. [Cytochrome p450 and their implication in chemotherapy].
    Delwaide PA
    Rev Med Liege; 1998 Nov; 53(11):700-10. PubMed ID: 9887664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ethnic background related pharmacological differences].
    Reinbold H
    MMW Fortschr Med; 2007 Oct; 149(42):34, 36. PubMed ID: 17987717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances: the cytochrome P450 enzymes.
    Slaughter RL; Edwards DJ
    Ann Pharmacother; 1995 Jun; 29(6):619-24. PubMed ID: 7663035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human cytochrome P-450 (CYP) genes: a web page for the nomenclature of alleles.
    Ingelman-Sundberg M; Oscarson M; Daly AK; Garte S; Nebert DW
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1307-8. PubMed ID: 11751452
    [No Abstract]   [Full Text] [Related]  

  • 25. Standardizing mutation nomenclature: why bother?
    den Dunnen JT; Paalman MH
    Hum Mutat; 2003 Sep; 22(3):181-2. PubMed ID: 12938082
    [No Abstract]   [Full Text] [Related]  

  • 26. Metabolism-based drug-drug interactions: what determines individual variability in cytochrome P450 induction?
    Tang C; Lin JH; Lu AY
    Drug Metab Dispos; 2005 May; 33(5):603-13. PubMed ID: 15673596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug metabolism by the cytochrome p-450 enzyme. Variability of polymorphisms and exogenous carriers].
    Kreutzkamp B
    Med Monatsschr Pharm; 2006 Feb; 29(2):48-50. PubMed ID: 16506587
    [No Abstract]   [Full Text] [Related]  

  • 28. Factors that decrease the effectiveness of clopidogrel.
    Aschenbrenner DS
    Am J Nurs; 2009 Jun; 109(6):66-7. PubMed ID: 19478613
    [No Abstract]   [Full Text] [Related]  

  • 29. Is genetic testing for cytochrome P450 polymorphisms ready for implementation?
    Matchar DB; Thakur M
    Am Fam Physician; 2007 Aug; 76(3):348, 351. PubMed ID: 17708133
    [No Abstract]   [Full Text] [Related]  

  • 30. Human CYP allele database: submission criteria procedures and objectives.
    Ingelman-Sundberg M; Oscarson M
    Methods Enzymol; 2002; 357():28-36. PubMed ID: 12424894
    [No Abstract]   [Full Text] [Related]  

  • 31. Update on allele nomenclature for human cytochromes P450 and the Human Cytochrome P450 Allele (CYP-allele) Nomenclature Database.
    Sim SC; Ingelman-Sundberg M
    Methods Mol Biol; 2013; 987():251-9. PubMed ID: 23475683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of human hepatic cytochromes P450 in drug metabolism and toxicity.
    George J; Farrell GC
    Aust N Z J Med; 1991 Jun; 21(3):356-62. PubMed ID: 1953519
    [No Abstract]   [Full Text] [Related]  

  • 33. [Genetic control of maturation of drug metabolism].
    Cresteil T
    Arch Pediatr; 2001 May; 8 Suppl 2():347s-349s. PubMed ID: 11394112
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug-drug interactions and the cytochrome P450 system: an update.
    Shannon M
    Pediatr Emerg Care; 1997 Oct; 13(5):350-3. PubMed ID: 9368253
    [No Abstract]   [Full Text] [Related]  

  • 35. The potential of knockout mouse lines in defining the role of flavin-containing monooxygenases in drug metabolism.
    Shephard EA; Phillips IR
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1083-94. PubMed ID: 20629583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical significance of cytochrome P450 genetic polymorphism--part I. Enzymatic system of cytochrome P450 and cytochrome P450 1A2].
    Duricová J; Grundmann M
    Ceska Slov Farm; 2011 Jun; 60(3):110-5. PubMed ID: 21838140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compilation of a comprehensive gene panel for systematic assessment of genes that govern an individual's drug responses.
    Feng J; Sun J; Wang MZ; Zhang Z; Kim ST; Zhu Y; Sun J; Xu J
    Pharmacogenomics; 2010 Oct; 11(10):1403-25. PubMed ID: 21047203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of the P450 gene superfamily and regulation of the murine Cyp1a1 gene.
    Puga A; Nebert DW
    Biochem Soc Trans; 1990 Feb; 18(1):7-10. PubMed ID: 2185093
    [No Abstract]   [Full Text] [Related]  

  • 39. Are non-human primates useful experimental animals for pre-clinical study?
    Hosokawa M
    Drug Metab Pharmacokinet; 2010; 25(3):221-2. PubMed ID: 20610880
    [No Abstract]   [Full Text] [Related]  

  • 40. Confounding factors for sex differences in pharmacokinetics and pharmacodynamics: focus on dosing regimen, dosage form, and formulation.
    Chen ML
    Clin Pharmacol Ther; 2005 Oct; 78(4):322-9. PubMed ID: 16198651
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.